Allogene Therapeutics, Inc.

Patient Square Capital LP ALLO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

4,963,756

Value ($000)

6,800

Weight

1.5%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	6,800	1.5%	4,963,756	12/31/2025
2025 Q3	11/10/2025	3,697	1.0%	2,981,396	9/30/2025
2025 Q2	8/11/2025	2,978	1.1%	2,635,000	6/30/2025